Literature DB >> 1974235

Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ)

P Gionchetti, C Guarnieri, M Campieri, A Belluzzi, C Brignola, P Iannone, M Miglioli, L Barbara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1974235      PMCID： PMC1378512          DOI： 10.1136/gut.31.6.730-b

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  5 in total

1.  Effect of sulphasalazine and its active metabolite, 5-amino-salicylic acid, on toxic oxygen metabolite production by neutrophils.

Authors:  J G Williams; M B Hallett
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

2.  Electrolytes and whole body potassium in acute leukemia.

Authors:  B Lantz; B Carlmark; P Reizenstein
Journal:  Acta Med Scand       Date:  1979

3.  Inhibition of neutrophil degranulation and superoxide production by sulfasalazine. Comparison with 5-aminosalicylic acid, sulfapyridine and olsalazine.

Authors:  T M Neal; C C Winterbourn; M C Vissers
Journal:  Biochem Pharmacol       Date:  1987-09-01       Impact factor: 5.858

4.  Actions of sulfasalazine and 5-aminosalicylic acid as reactive oxygen scavengers in the suppression of bile acid-induced increases in colonic epithelial cell loss and proliferative activity.

Authors:  P A Craven; J Pfanstiel; R Saito; F R DeRubertis
Journal:  Gastroenterology       Date:  1987-06       Impact factor: 22.682

5.  Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.

Authors:  Y Miyachi; A Yoshioka; S Imamura; Y Niwa
Journal:  Gut       Date:  1987-02       Impact factor: 23.059
  5 in total
  4 in total

Review 1.  Targeting mitochondrial function for the treatment of acute spinal cord injury.

Authors:  Melanie L McEwen; Patrick G Sullivan; Alexander G Rabchevsky; Joe E Springer
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

Review 2.  Olsalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in inflammatory bowel disease.

Authors:  A N Wadworth; A Fitton
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

3.  The functional and neuroprotective actions of Neu2000, a dual-acting pharmacological agent, in the treatment of acute spinal cord injury.

Authors:  Joe E Springer; Ravikumar Rangaswamy Rao; Hyang Ran Lim; Sung Ig Cho; Gyoeng Joon Moon; Hee Young Lee; Eui Jin Park; Jai Sung Noh; Byoung Joo Gwag
Journal:  J Neurotrauma       Date:  2010-01       Impact factor: 5.269

4.  Antioxidant properties of mesalamine in colitis inhibit phosphoinositide 3-kinase signaling in progenitor cells.

Authors:  Elizabeth Managlia; Rebecca B Katzman; Jeffrey B Brown; Terrence A Barrett
Journal:  Inflamm Bowel Dis       Date:  2013-09       Impact factor: 5.325
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.